- San Diego Encouraged to Save Lids to Save Lives®
Yoplait’s signature pink lid program Save Lids to Save Lives®, is taking place during September and October 2010 to once again raise funds for Susan G. Komen for the Cure®, the world’s largest grassroots network of breast cancer survivors and activists. Community members of San Diego are encouraged to collect the special pink yogurt lids as proceeds will benefit the local Susan G. Komen for the Cure®, San Diego Affiliate of Susan G. Komen for the Cure®.
(Filed: Sat Aug 28 2010)
- Are Baby Boomers in a Medical Crisis?
As the year 2011 approaches the first wave of baby boomers will reach retirement age. In past generations, families were large and there were a number of children to take care of the elderly.
(Filed: Wed Aug 25 2010)
- Looking Good: Plastic & Aesthetic Surgery in Germany
Looking good has never been easier, and more affordable. Millions of men and women around the world are seeking plastic and aesthetic surgical techniques and procedures for a variety of reasons; beauty, anti-aging, and even to help compete in today's highly competitive economy.
(Filed: Wed Aug 25 2010)
- Medelita Women’s Lab Coat Goes to White House
AMWA members receive 15% discount on all scrubs, medical clogs and lab coats, including the style worn by its president Dr. Eliza Chin to a meeting with First Lady Michelle Obama
(Filed: Wed Aug 25 2010)
- Steve Coats at MedImmune to speak at Cancer conference Oct, 20-22, 2010 CA-SF
Dr. Steve Coats, Director of Oncology Research at MedImmune, will give a presentation on “Development of a Novel Human Therapeutic Antibody That Targets the PDGF Signaling Pathway for Cancer Therapy” at the 2nd Annual Cancer Targets and Therapeutics Conference, part of the 6th Modern Drug Discovery and Development Summit, held in San Francisco, CA Oct. 20-22, 2010 by GTCbio.
(Filed: Wed Aug 25 2010)
- Cryo-Cell Announces Celle(SM) Research and Development Collaboration with Department of Medicine, Mo
The partnership between Cryo-Cell and MNHS will support an exciting new area of research that will investigate potential benefits of a new and non-invasive way to utilize Cryo-Cell's proprietary menstrual blood stem cell technology to potentially manipulate the immune system to remove or control autoreactive cells that would normally be involved in inducing multiple sclerosis. This concept may further demonstrate potential to reverse established disease.
(Filed: Mon Aug 23 2010)
- Mathai Mammen SVP at Theravance to speak at Modern Drug Summit Oct 20 CA-SF
Mathai Mammen, Senior Vice President of Research and Early Clinical Development at Theravance will give a plenary keynote presentation on “Multivalent Design in Drug Discovery” at the 6th Modern Drug Discovery and Development Summit to be held this year in San Francisco, CA on Oct 20-22, 2010 by GTCbio. Theravance leverages Multivalent Design to install useful molecular features, such as high potency, high selectivity, duration of action, and activity at a second biological target to create novel and highly differentiated medicines. Examples of drugs and candidates in Development created by the use of Multivalent Design include the following: VIBATIVTM (telavancin) an antibiotic with two complementary pharmacologies approved in 2009 for the treatment of adult patients with complicated skin and skin structure infections; TD-1792, a second antibiotic with two different complementary pharmacologies that has completed a Phase 2 study in complicated skin and skin structure infections; and TD-5959, which as a single molecule acts to both agonize the 2 adrenoreceptor and antagonize the M3 muscarinic receptor, has completed Phase 2a studies in Chronic Obstructive Pulmonary Disease. The discovery and characterization of these compounds will be described to illustrate the utility, depth and breadth of Multivalent Design in Drug Discovery
(Filed: Sun Aug 22 2010)
- Botox Training with the IAPAM Can Help Physicians Boost Profits
As the demand for minimally-invasive treatments continues to rise, specifically the demand for Botox and other cosmetic injectables, physicians who are expertly trained through accredited multi-day training programs like the International Association for Physicians in Aesthetic Medicine's (IAPAM's) Aesthetic Medicine Symposium, can capture the lion's share of this growing market and greatly benefit their bottom lines.
(Filed: Fri Aug 20 2010)
- Focusing on Women at Adiva
Adiva Healthcare is a part of the “Mother’s Pride Group" which owns and manages 38 branches of pre schools along with 6 senior secondary schools. Adiva has its main branch in an excellent location with state-of-the-art infrastructure in New Delhi to caters to all needs of women and to celebrate womanhood.
(Filed: Fri Aug 20 2010)
- Physicians Place Prevention at the Top of Their Prescription Pads
BodyLogicMD bioidentical hormone doctors offer insight to new trend that focuses on helping women and men manage the aging process – as well as the negative effects of poor diet, lack of exercise, environmental toxins and hormone imbalance – through prevention.
(Filed: Fri Aug 20 2010)
- Saving Big on Top 7 Medical Procedures Overseas
Travelers are globe-trotting these days to destinations around the world are increasingly popular for seven types of medical care, driven by excellent care, lower costs, beautiful and unforgettable locations and faster health care services.
(Filed: Fri Aug 20 2010)
- Mineral Makeup Helps Charitable Cause
Afterglow Cosmetics is helping the Young Survival Coalition with every purchase of organic lipstick. For every tube sold $2 is donated to charity. Learn more or order at http://www.afterglowcosmetics.com/.
(Filed: Wed Aug 18 2010)
- Susan G. Komen for the Cure® Partners with Massage Envy® for 6th Annual Massage for the Cure®
Susan G. Komen for the Cure® is partnering with Massage Envy® for the 6th Annual Massage for the Cure® on Tuesday, September 14. Massage for the Cure® is a one-day event presented by Massage Envy® offering one-hour therapeutic massage sessions for $49, with $15 from each massage being donated to Susan G. Komen for the Cure®. 100% of the funds raised will be given to Komen Affiliates to be used for breast cancer education, screening and treatment programs.
(Filed: Wed Aug 18 2010)
|
